• 2011

Company Description

Maryland startup BeneVir is developing immunotherapy viruses that rid the body of two types of tumor cells.

BeneVir's immunotherapies for cancer are designed to induce the immune system to rid the body of two types of tumor cells: those currently responsible for cancer and those responsible for tumor recurrence and poor clinical outcomes. This is a unique approach in the emerging field of cancer immunotherapy.